Legend Biotech Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025

Published: 2025-05-13 07:00:00 ET LEGN

Published on 05/13/2025 at 07:00, updated on 05/13/2025 at 08:50

Legend Biotech Corporation reported earnings results for the first quarter ended March 31, 2025. For the first quarter, the company reported revenue was USD 195.05 million compared to USD 93.99 million a year ago. Net loss was USD 100.92 million compared to USD 59.79 million a year ago.

Basic loss per share from continuing operations was USD 0.54 compared to USD 0.32 a year ago. Diluted loss per share from continuing operations was USD 0.54 compared to USD 0.32 a year ago.